ES2069682T3 - Analogos de prostaglandina de amida heterociclica sustituida con interfenileno-7-oxabicicloheptilo utiles en el tratamiento de enfermedades tromboticas y vasoespasticas. - Google Patents

Analogos de prostaglandina de amida heterociclica sustituida con interfenileno-7-oxabicicloheptilo utiles en el tratamiento de enfermedades tromboticas y vasoespasticas.

Info

Publication number
ES2069682T3
ES2069682T3 ES90303537T ES90303537T ES2069682T3 ES 2069682 T3 ES2069682 T3 ES 2069682T3 ES 90303537 T ES90303537 T ES 90303537T ES 90303537 T ES90303537 T ES 90303537T ES 2069682 T3 ES2069682 T3 ES 2069682T3
Authority
ES
Spain
Prior art keywords
aralkyl
aryl
useful
substituted
thrombotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90303537T
Other languages
English (en)
Inventor
Raj Narain Misra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of ES2069682T3 publication Critical patent/ES2069682T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PROVEE INTERFENILENO 7-OXABICICLOHEPTILO SUSTITUIDA ANALOGO DE PROSTAGLANDINA EL CUAL DE USA EN EL TRATAMIENTO DE ENFERMEDADES TROMBOTICAS Y VASOPATICAS Y TIENE LA FORMULA ESTRUCTURAL EN DONDE M ES 1, 2 O 3; N ES 0, 1, 2, 3 O 4; Y ES O, VINILO O UN ENLACE SIMPLE, CON LA PROVISION DE QUE CUANDO N ES 0, Y ES UN ENLACE SIMPLE; R ES CO2H, CO2 METAL ALCALINO, CO2 ALQUILO INFERIOR, CH2OH, CONHSO2R3, CONHR3A O 5-TETRAZOLILO, CON LA PROVISION QUE CUANDO R ES 5-TETRAZOLILO, N ES DISTINTO DE CERO; X ES O, S O NH; R1 ES HIDROGENO, ALQUILO INFERIOR, ALQUENILO INFERIOR, ALQUINILO INFERIOR, ARILO, ARILOALQUILO, CICLOALQUILO, CICLOALQUILOALQUILO, HETEROCICLO SATURADO, HETERO CICLOALQUILO SATURADO, HETEROCICLO AROMATICO, HETEROCICLOALQUILO O AMIDO AROMATICO; CADA UNO OPCIONALMENTE SUSTITUIDO CON UN ALQUILO, ARILO, CICLOALQUILO, O CICLOALQUILOALQUILO; Y R2 ES HIDROGENO, ALQUILO INFERIOR, ARILO, O ARILOALQUILO, O R1 Y R2 JUNTO CON EL NITROGENO AL CUAL ESTAN UNIDOS FORMAN UN ANILLO DE 5 A 8 MIEMBROS; R3 ES ALQUILO INFERIOR, ARILO O ARILOALQUILO Y R3A ES HIDROGENO, ALQUILO INFERIOR, AROILO, O ARILOALQUILO.
ES90303537T 1989-04-03 1990-04-02 Analogos de prostaglandina de amida heterociclica sustituida con interfenileno-7-oxabicicloheptilo utiles en el tratamiento de enfermedades tromboticas y vasoespasticas. Expired - Lifetime ES2069682T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33407089A 1989-04-03 1989-04-03

Publications (1)

Publication Number Publication Date
ES2069682T3 true ES2069682T3 (es) 1995-05-16

Family

ID=23305449

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90303537T Expired - Lifetime ES2069682T3 (es) 1989-04-03 1990-04-02 Analogos de prostaglandina de amida heterociclica sustituida con interfenileno-7-oxabicicloheptilo utiles en el tratamiento de enfermedades tromboticas y vasoespasticas.

Country Status (28)

Country Link
EP (1) EP0391652B1 (es)
JP (1) JP2989213B2 (es)
KR (1) KR0160508B1 (es)
CN (1) CN1028529C (es)
AT (1) ATE119903T1 (es)
AU (1) AU632797B2 (es)
CA (1) CA2012267C (es)
CY (1) CY1851A (es)
CZ (1) CZ285656B6 (es)
DD (1) DD293353A5 (es)
DE (1) DE69017735T2 (es)
DK (1) DK0391652T3 (es)
EG (1) EG19080A (es)
ES (1) ES2069682T3 (es)
FI (1) FI97543C (es)
HK (1) HK110495A (es)
HU (2) HUT54368A (es)
IE (1) IE67274B1 (es)
IL (1) IL93771A (es)
MX (1) MX20132A (es)
MY (1) MY106245A (es)
NO (1) NO177425C (es)
NZ (1) NZ232897A (es)
PL (1) PL164345B1 (es)
PT (1) PT93641B (es)
RU (1) RU2059618C1 (es)
SK (1) SK158290A3 (es)
ZA (1) ZA902559B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5550248A (en) * 1990-11-29 1996-08-27 E.R. Squibb & Sons, Inc. Substituted stryl heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5238951A (en) * 1991-02-01 1993-08-24 E. R. Squibb & Sons, Inc. Heterocyclic amido prostaglandin analogs
IE920039A1 (en) * 1991-02-01 1992-08-12 Squibb & Sons Inc Heterocyclic amido prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5162352A (en) * 1991-08-22 1992-11-10 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs
CA2081679A1 (en) * 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5281716A (en) * 1992-06-18 1994-01-25 Bristol-Myers Squibb Company Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
US5539126A (en) * 1994-04-20 1996-07-23 Bristol-Myers Squibb Company Method for preparing homochiral maleimide intermediates, via silylation techniques
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5856584A (en) * 1997-08-06 1999-01-05 The Nutrasweet Company Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3, 3-dimethylbutanol
US5905175A (en) * 1998-05-20 1999-05-18 The Nutrasweet Company Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide
US6407250B1 (en) 2000-09-14 2002-06-18 Allergan Sales, Inc. Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
US6511999B2 (en) 2000-09-14 2003-01-28 Allergan, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6369089B1 (en) 2000-09-14 2002-04-09 Allergan Sales, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US7045634B2 (en) 2003-09-05 2006-05-16 Allergan, Inc. Prostamide receptor antagonists
AU2010232556A1 (en) 2009-04-02 2011-11-03 Allergan, Inc. Prostaglandin E receptor antagonists
CA2837300A1 (en) * 2011-05-25 2012-11-29 Allergan, Inc. Fatty acid amide hydrolase inhibitors for treating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652576A (en) * 1985-10-18 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease
CA2006355A1 (en) * 1988-12-23 1990-06-23 Philip M. Sher 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions

Also Published As

Publication number Publication date
SK278865B6 (sk) 1998-04-08
HU9002048D0 (en) 1990-08-28
FI901645A0 (fi) 1990-04-02
CA2012267C (en) 2001-02-27
AU632797B2 (en) 1993-01-14
EG19080A (en) 1994-07-30
ZA902559B (en) 1991-01-30
IL93771A (en) 1995-06-29
CN1046163A (zh) 1990-10-17
PT93641A (pt) 1990-11-20
DD293353A5 (de) 1991-08-29
DK0391652T3 (da) 1995-04-03
CA2012267A1 (en) 1990-10-03
CZ158290A3 (cs) 1999-06-16
NO177425C (no) 1995-09-20
NO177425B (no) 1995-06-06
MY106245A (en) 1995-04-29
ATE119903T1 (de) 1995-04-15
HU210713A9 (en) 1995-06-28
EP0391652B1 (en) 1995-03-15
AU5206490A (en) 1990-10-04
CY1851A (en) 1996-03-08
KR0160508B1 (ko) 1998-12-01
JPH02289579A (ja) 1990-11-29
RU2059618C1 (ru) 1996-05-10
KR900016197A (ko) 1990-11-12
NZ232897A (en) 1992-12-23
PL284600A1 (en) 1991-01-14
DE69017735D1 (de) 1995-04-20
NO901494L (no) 1990-10-04
SK158290A3 (en) 1998-04-08
IE901095L (en) 1990-10-03
JP2989213B2 (ja) 1999-12-13
HUT54368A (en) 1991-02-28
CN1028529C (zh) 1995-05-24
IL93771A0 (en) 1990-12-23
CZ285656B6 (cs) 1999-10-13
FI97543C (fi) 1997-01-10
NO901494D0 (no) 1990-04-02
HK110495A (en) 1995-07-14
PL164345B1 (pl) 1994-07-29
MX20132A (es) 1994-01-31
DE69017735T2 (de) 1995-08-17
PT93641B (pt) 1996-06-28
IE67274B1 (en) 1996-03-20
EP0391652A1 (en) 1990-10-10
FI97543B (fi) 1996-09-30

Similar Documents

Publication Publication Date Title
ES2069682T3 (es) Analogos de prostaglandina de amida heterociclica sustituida con interfenileno-7-oxabicicloheptilo utiles en el tratamiento de enfermedades tromboticas y vasoespasticas.
DE3855099D1 (de) Nucleoside zur Verwendung für die Therapie
FI932445A0 (fi) Farmaceutiska foereningar
NO863718L (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
DE68912459D1 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten.
FI98125B (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
OA09016A (fr) Produits cathartiques.
FR2401913A1 (fr) Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant
ES2132279T3 (es) Analogo de prostaglandina.
EP0364559A4 (en) Substituted adenine derivatives useful as therapeutic agents
DK707988D0 (da) Fremgangsmaade til at haemme virus
PT86032A (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung
GR3015704T3 (en) Glycerin derivative and its pharmacological use.
CA1270842C (en) 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs
HUT56559A (en) Process for producing ascorbinic acid derivatives and pharma
ATE94402T1 (de) Peptid fk-565, brauchbar zur kontrolle helminthischer parasiten.
ATE82748T1 (de) Verfahren und zwischenprodukte.
IT8714709V0 (it) Accorgimenti per montare celermente gli apripista sui trattori agricoli senza pregiudicare la necessaria resistenza meccanica dell'insieme
SE8600132D0 (sv) Las avsett for ramar
DE69127367D1 (de) Aluminium-Kalium-Sulfat enthaltende Creme und Verfahren zur Herstellung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 391652

Country of ref document: ES